Latvia Diabetes Medicine Sales is set to reach $38.9 Million by 2026 from $34.1 Million, will grow 7.8% per year. Canada, Spain and Italy respectively came in numbers 2, 3 and 4 in this ranking.
Latvia Diabetes Medicine Sales is set to reach $38.9 Million by 2026 from $34.1 Million, will grow 7.8% per year. Canada, Spain and Italy respectively came in numbers 2, 3 and 4 in this ranking.